AllianceBernstein
CNST

AllianceBernstein’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

AllianceBernstein’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-508,375
Closed -$17.2M – 3419
2021
Q2 		$17.2M Buy
508,375
+471,575
+1,281% +$12M 0.01% 1002
2021
Q1 		$861K Sell
36,800
-91,558
-71% -$2.77M ﹤0.01% 2473
2020
Q4 		$3.7M Buy
128,358
+35,417
+38% +$892K ﹤0.01% 1664
2020
Q3 		$1.88M Sell
92,941
-396
-0.4% -$9.67K ﹤0.01% 1884
2020
Q2 		$2.81M Buy
93,337
+10,224
+12% +$368K ﹤0.01% 1648
2020
Q1 		$2.61M Buy
83,113
+64,913
+357% +$2.26M ﹤0.01% 1512
2019
Q4 		$857K Buy
+18,200
New +$525K ﹤0.01% 2341

AllianceBernstein's CNST Position: Q3 2021 in Review

AllianceBernstein sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 508,375 shares — an estimated $17.2M sold.

AllianceBernstein first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $17.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • AllianceBernstein reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • AllianceBernstein sold 508,375 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $17.2M.
  • AllianceBernstein first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
  • AllianceBernstein's Constellation Pharmaceuticals, Inc. position peaked at $17.2M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.